Summary & Overview
CPT 83030: Detection and Quantitation of Fetal Hemoglobin
CPT code 83030 represents a laboratory procedure for the detection and quantitation of fetal hemoglobin in whole blood. This test is clinically relevant for diagnosing and monitoring hemoglobinopathies such as sickle cell disease and certain thalassemias, and it can influence treatment decisions and transfusion management. Nationally, accurate coding for this assay supports appropriate laboratory billing, clinical documentation, and population-level tracking of hemoglobin disorder care.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines common coverage considerations and payer approaches without making recommendations to providers.
Readers will learn the clinical context for 83030, the typical service setting, and which stakeholders are commonly involved in reimbursement decisions. The content summarizes benchmark concepts, coding guidance essentials, and policy-related considerations affecting laboratory reimbursement and reporting. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 83030 describes a chemical test for the detection and quantitation of fetal hemoglobin, typically performed on a whole blood sample. The procedure is used to determine the proportion of fetal hemoglobin present, which can inform diagnosis and monitoring of hemoglobinopathies and other hematologic conditions.
Service Type: Clinical laboratory testing / Hemoglobin fractionation
Typical Site of Service: Clinical laboratory or hospital laboratory setting
Clinical & Coding Specifications
Clinical Context
A newborn infant or pediatric patient presents with anemia, jaundice, or a positive newborn screening result suggesting a hemoglobinopathy. A whole blood sample is collected in EDTA and sent to the clinical laboratory for quantitation of fetal hemoglobin using a chemical or chromatographic method. The laboratory analyst performs 83030 to detect and measure percent fetal hemoglobin (HbF) to aid in the diagnosis and monitoring of conditions such as beta thalassemia, sickle cell disease, hereditary persistence of fetal hemoglobin, and evaluation of transfusion effects. Results are reported to the ordering provider (commonly a pediatrician, neonatologist, hematologist, or primary care physician) and incorporated into the clinical workflow for diagnosis confirmation, genetic counseling, and treatment planning. Typical sites of service include hospital inpatient laboratories, hospital outpatient or ambulatory lab draw sites, and independent clinical reference laboratories.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | Default/No modifier | Use when no specific modifier applies to the billed service. |
11 |